Biophytis announces its participation in the BIO International Convention from June 16 to 19
Biophytis announces its participation to the BIO International Convention, which will take place this year in Boston, USA, from June 16 to 19, 2025.
Edouard Bieth, Chief Strategy Officer at Biophytis, will be present and will take part in numerous meetings throughout the Convention. The goal is to present the Company’s latest developments, particularly regarding its drug candidate BIO101, including its Phase 2 OBA study in obesity.
This will also be an opportunity to engage with many international pharmaceutical players and explore potential research or commercialization partnerships.
About the BIO International Convention
The BIO International Convention is the largest event dedicated to biotechnology. It brings together the entire biotech ecosystem, with 20,000 industry leaders from around the world. The convention aims to unite public pharmaceutical companies, biotech startups, academic institutions, non-profit organizations, government agencies, as well as researchers, business development professionals, and investors.
For more information see here.